BRPI0913805A2 - composto - Google Patents
compostoInfo
- Publication number
- BRPI0913805A2 BRPI0913805A2 BRPI0913805A BRPI0913805A BRPI0913805A2 BR PI0913805 A2 BRPI0913805 A2 BR PI0913805A2 BR PI0913805 A BRPI0913805 A BR PI0913805A BR PI0913805 A BRPI0913805 A BR PI0913805A BR PI0913805 A2 BRPI0913805 A2 BR PI0913805A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10516708P | 2008-10-14 | 2008-10-14 | |
| PCT/US2009/060473 WO2010045212A2 (en) | 2008-10-14 | 2009-10-13 | Nicotinic acetylcholine receptor ligands and the uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0913805A2 true BRPI0913805A2 (pt) | 2016-11-01 |
Family
ID=42107175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0913805A BRPI0913805A2 (pt) | 2008-10-14 | 2009-10-13 | composto |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8445684B2 (pt) |
| EP (1) | EP2342192A4 (pt) |
| JP (1) | JP2012505834A (pt) |
| KR (1) | KR20110091501A (pt) |
| CN (1) | CN102216289A (pt) |
| AU (1) | AU2009303545A1 (pt) |
| BR (1) | BRPI0913805A2 (pt) |
| CA (1) | CA2738806A1 (pt) |
| IL (1) | IL211569A0 (pt) |
| MX (1) | MX2011003306A (pt) |
| WO (1) | WO2010045212A2 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5528434B2 (ja) * | 2008-05-23 | 2014-06-25 | ジョージタウン ユニヴァーシティー | ニューロンｎＡＣｈＲの無痛性脱感作剤およびその使用方法 |
| KR20110091501A (ko) | 2008-10-14 | 2011-08-11 | 싸이코제닉스 아이엔씨. | 니코틴성 아세틸콜린 수용체 리간드 및 이들의 용도 |
| DK3439661T3 (da) * | 2016-04-07 | 2021-10-18 | Oyster Point Pharma Inc | Fremgangsmåder til behandling af øjenlidelser |
| CN113341066B (zh) * | 2021-05-24 | 2022-04-08 | 西南石油大学 | 基于多传感器融合技术的四氢噻吩浓度的在线检测方法及系统 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341554C (en) * | 1988-03-18 | 2007-10-09 | The Salk Institute For Biological Studies | Neuronal nicotinic acetylcholine receptor compositions and assay |
| DE69033214T2 (de) | 1989-03-14 | 1999-12-09 | Salk Inst For Biolog Studies L | Neuronale nikotinacetylcholinrezeptorzusammensetzungen enthaltend die beta-4 subeinheit |
| IL107184A (en) * | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
| US5914328A (en) * | 1992-10-09 | 1999-06-22 | Abbott Laboratories | Heterocyclic ether compounds useful in controlling neurotransmitter release |
| US5948793A (en) * | 1992-10-09 | 1999-09-07 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release |
| IL118279A (en) | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
| US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| US6437138B1 (en) * | 1996-06-06 | 2002-08-20 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| TR199901904T2 (xx) | 1996-12-10 | 1999-10-21 | Abbott Laboratories | 3-piridil enantiyomerleri ve bunlar�n analjezik olarak kullan�lmas�. |
| DK1047690T3 (da) | 1997-12-19 | 2004-07-05 | Abbott Lab | Heterocykliske ether- og thioetherforbindelser, som er anvendelige til regulering af kemisk, synaptisk overförsel |
| EP1147112B1 (en) * | 1999-01-29 | 2003-10-29 | Abbott Laboratories | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| WO2000064885A1 (en) * | 1999-04-26 | 2000-11-02 | Neurosearch A/S | Heteroaryl diazacycloalkanes, their preparation and use |
| AU5900700A (en) | 1999-08-31 | 2001-03-26 | Targacept, Inc. | Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| CA2381252A1 (en) * | 1999-09-14 | 2001-03-22 | Abbott Laboratories | 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| US6277855B1 (en) * | 2000-04-21 | 2001-08-21 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| US8030300B2 (en) * | 2003-06-10 | 2011-10-04 | Georgetown University | Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| US20080176826A1 (en) * | 2005-05-25 | 2008-07-24 | Michael Puhl | Pyridine Compounds For Combating Arthropod Pests and Nematodes |
| US20070184490A1 (en) | 2006-01-17 | 2007-08-09 | Marleen Verlinden | Neuronal nicotinic receptor ligands and their use |
| TW200800020A (en) * | 2006-01-26 | 2008-01-01 | Basf Ag | Methods to use 3-pyridyl derivatives as pesticides |
| FR2896800B1 (fr) * | 2006-01-30 | 2008-04-11 | Servier Lab | Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US8642612B2 (en) * | 2006-07-18 | 2014-02-04 | Potomac Pharmaceuticals, Inc. | Nicotinic desensitizers and methods of selecting, testing, and using them |
| JP2009143507A (ja) * | 2007-12-18 | 2009-07-02 | Nissan Motor Co Ltd | 車両用収納装置 |
| JP5528434B2 (ja) * | 2008-05-23 | 2014-06-25 | ジョージタウン ユニヴァーシティー | ニューロンｎＡＣｈＲの無痛性脱感作剤およびその使用方法 |
| KR20110091501A (ko) | 2008-10-14 | 2011-08-11 | 싸이코제닉스 아이엔씨. | 니코틴성 아세틸콜린 수용체 리간드 및 이들의 용도 |
-
2009
- 2009-10-13 KR KR1020117008494A patent/KR20110091501A/ko not_active Withdrawn
- 2009-10-13 WO PCT/US2009/060473 patent/WO2010045212A2/en not_active Ceased
- 2009-10-13 JP JP2011531253A patent/JP2012505834A/ja active Pending
- 2009-10-13 CN CN2009801458813A patent/CN102216289A/zh active Pending
- 2009-10-13 EP EP09821104A patent/EP2342192A4/en not_active Withdrawn
- 2009-10-13 CA CA2738806A patent/CA2738806A1/en not_active Abandoned
- 2009-10-13 BR BRPI0913805A patent/BRPI0913805A2/pt not_active IP Right Cessation
- 2009-10-13 AU AU2009303545A patent/AU2009303545A1/en not_active Abandoned
- 2009-10-13 US US12/578,020 patent/US8445684B2/en not_active Expired - Fee Related
- 2009-10-13 MX MX2011003306A patent/MX2011003306A/es not_active Application Discontinuation
-
2011
- 2011-03-03 IL IL211569A patent/IL211569A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110091501A (ko) | 2011-08-11 |
| WO2010045212A2 (en) | 2010-04-22 |
| US8445684B2 (en) | 2013-05-21 |
| AU2009303545A1 (en) | 2010-04-22 |
| WO2010045212A3 (en) | 2010-07-29 |
| CN102216289A (zh) | 2011-10-12 |
| IL211569A0 (en) | 2011-05-31 |
| EP2342192A4 (en) | 2012-05-09 |
| CA2738806A1 (en) | 2010-04-22 |
| MX2011003306A (es) | 2011-09-01 |
| JP2012505834A (ja) | 2012-03-08 |
| US20100152450A1 (en) | 2010-06-17 |
| EP2342192A2 (en) | 2011-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20210049I1 (fi) | Satralitsumabi | |
| NO2018006I1 (no) | Atezolizumab | |
| FIC20170031I1 (fi) | alirokumabi | |
| DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
| BRPI0920707A2 (pt) | compostos | |
| DK2242759T3 (da) | Forbindelser | |
| DK2340021T3 (da) | Substituerede pyrrolidin-2-carboxamider | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| FI20085383A0 (fi) | Matonpesulaitteisto | |
| BRPI0918602A2 (pt) | composto (i) | |
| DK2323972T3 (da) | C7-fluor-substituerede tetracylinforbindelser | |
| DK2297162T3 (da) | Forbindelser | |
| DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
| BRPI0907522A2 (pt) | biarlamidas | |
| BRPI0916432A2 (pt) | compostos | |
| DE602008004695D1 (de) | Katalysatorträgerwabe | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| BRPI0923592A2 (pt) | composto | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| BRPI0911393A2 (pt) | composto de 5-hidroxipirimidina-4-carboxamida | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas | |
| BRPI0909637A2 (pt) | 2-aminoquinolinas | |
| DK2206698T3 (da) | Ethynylindolforbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15I | Others concerning applications: loss of priority |
Free format text: OBSERVA-SE QUE A PRIORIDADE REQUERIDA US 61/105,167 DE 14.10.2008 POSSUI DEPOSITANTE DIFERENTE DO INFORMADO NA ENTRADA NA FASE NACIONAL E SUA RESPECTIVA CESSAO FOI APRESENTADA EM 20/09/2011, APOS O PRAZO REGULAR DE 60 DIAS QUE SE ENCERRAVA EM 25/05/2011, MOTIVO PELO QUAL SERA DADA PERDA DESTA PRIORIDADE, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |